HomeCompareCTRRF vs JNJ

CTRRF vs JNJ: Dividend Comparison 2026

CTRRF yields 5.55% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CTRRF wins by $11222.86M in total portfolio value
10 years
CTRRF
CTRRF
● Live price
5.55%
Share price
$12.28
Annual div
$0.68
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11222.88M
Annual income
$10,847,654,284.63
Full CTRRF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CTRRF vs JNJ

📍 CTRRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTRRFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTRRF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CTRRF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTRRF
Annual income on $10K today (after 15% tax)
$472.07/yr
After 10yr DRIP, annual income (after tax)
$9,220,506,141.94/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, CTRRF beats the other by $9,220,505,438.32/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTRRF + JNJ for your $10,000?

CTRRF: 50%JNJ: 50%
100% JNJ50/50100% CTRRF
Portfolio after 10yr
$5611.45M
Annual income
$5,423,827,556.21/yr
Blended yield
96.66%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CTRRF
No analyst data
Altman Z
1.2
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTRRF buys
0
JNJ buys
0
No recent congressional trades found for CTRRF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTRRFJNJ
Forward yield5.55%3.36%
Annual dividend / share$0.68$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR100%5.8%
Portfolio after 10y$11222.88M$20.0K
Annual income after 10y$10,847,654,284.63$827.78
Total dividends collected$11196.75M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CTRRF vs JNJ ($10,000, DRIP)

YearCTRRF PortfolioCTRRF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,811$1,110.75$10,676$355.77+$1.1KCTRRF
2$15,090$2,452.11$11,407$389.39+$3.7KCTRRF
3$22,002$5,855.80$12,198$426.53+$9.8KCTRRF
4$39,501$15,959.18$13,056$467.62+$26.4KCTRRF
5$95,822$53,556.08$13,987$513.12+$81.8KCTRRF
6$345,366$242,835.93$14,998$563.56+$330.4KCTRRF
7$2,005,500$1,635,958.98$16,098$619.52+$1.99MCTRRF
8$19,902,584$17,756,699.15$17,295$681.69+$19.89MCTRRF
9$350,674,245$329,378,479.59$18,599$750.82+$350.66MCTRRF
10$11,222,875,727$10,847,654,284.63$20,022$827.78+$11222.86MCTRRF

CTRRF vs JNJ: Complete Analysis 2026

CTRRFStock

CT Real Estate Investment Trust (TSX:CRT.UN) is an unincorporated, closed-end real estate investment trust formed to own income-producing commercial properties primarily located in Canada. Its portfolio is comprised of over 350 properties totaling approximately 29 million square feet of GLA, consisting primarily of net leased single-tenant retail properties located across Canada. Canadian Tire Corporation, Limited is CT REIT's most significant tenant.

Full CTRRF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CTRRF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTRRF vs SCHDCTRRF vs JEPICTRRF vs OCTRRF vs KOCTRRF vs MAINCTRRF vs ABBVCTRRF vs MRKCTRRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.